See more : Unibap AB (publ) (UNIBAP.ST) Income Statement Analysis – Financial Results
Complete financial analysis of SEED Co.,Ltd. (7743.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SEED Co.,Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Concrete Pumping Holdings, Inc. WT EXP 080124 (BBCPW) Income Statement Analysis – Financial Results
- Absa Group Limited (AGRPF) Income Statement Analysis – Financial Results
- City Chic Collective Limited (CCX.AX) Income Statement Analysis – Financial Results
- DiDi Global Inc. (DIDIY) Income Statement Analysis – Financial Results
- Green Bridge Industries, Inc. (GRBG) Income Statement Analysis – Financial Results
SEED Co.,Ltd. (7743.T)
About SEED Co.,Ltd.
SEED Co.,Ltd. manufactures and supplies contact lenses, care products, spectacle frames, and other eye care products in Japan and internationally. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; SEED MonthlyFine UV and monthly color lens UV replacement contact lenses; rigid gas permeable contact lenses; and medical contact lenses. In addition, the company offers glass frames under the Vivid Moon, ViVi fleurs, and Plusmix brand names; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products for better vision. SEED Co., Ltd. was founded in 1957 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.40B | 30.59B | 28.84B | 28.62B | 31.79B | 29.49B | 27.83B | 24.46B | 21.83B | 18.73B | 19.18B | 15.04B | 12.67B | 11.81B | 11.13B | 9.86B | 10.38B |
| Cost of Revenue | 18.21B | 18.97B | 16.82B | 16.21B | 17.61B | 16.12B | 15.42B | 14.41B | 13.14B | 10.91B | 10.91B | 7.93B | 7.06B | 6.57B | 6.07B | 5.52B | 5.29B |
| Gross Profit | 14.18B | 11.62B | 12.01B | 12.41B | 14.18B | 13.37B | 12.41B | 10.05B | 8.69B | 7.82B | 8.27B | 7.11B | 5.60B | 5.24B | 5.06B | 4.34B | 5.09B |
| Gross Profit Ratio | 43.78% | 37.99% | 41.65% | 43.37% | 44.61% | 45.33% | 44.59% | 41.08% | 39.80% | 41.77% | 43.10% | 47.27% | 44.24% | 44.37% | 45.45% | 43.97% | 49.05% |
| Research & Development | 0.00 | 1.92B | 1.33B | 1.38B | 1.67B | 1.11B | 1.13B | 927.36M | 667.43M | 644.00M | 562.00M | 491.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 11.19B | 10.16B | 9.60B | 9.49B | 10.50B | 9.48B | 7.51B | 6.23B | 5.72B | 5.98B | 5.81B | 5.15B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 940.00M | 830.00M | 1.24B | 1.73B | 1.95B | 2.01B | 1.66B | 1.38B | 1.41B | 1.31B | 1.30B | 1.01B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 12.13B | 10.99B | 10.83B | 11.22B | 12.45B | 11.49B | 9.17B | 7.60B | 7.12B | 7.28B | 7.11B | 6.16B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 63.56M | 60.14M | 89.79M | 94.21M | 94.02M | 76.97M | 73.45M | 49.01M | 12.42M | 14.00M | 463.72M | 37.25M | 57.39M | 54.98M | 41.80M | 23.12M |
| Operating Expenses | 12.13B | 10.99B | 10.83B | 11.22B | 12.45B | 11.49B | 10.30B | 8.53B | 7.79B | 7.28B | 7.11B | 6.26B | 5.26B | 5.02B | 4.93B | 4.81B | 5.31B |
| Cost & Expenses | 30.35B | 29.96B | 27.66B | 27.42B | 30.06B | 27.62B | 25.72B | 22.94B | 20.93B | 18.19B | 18.02B | 14.19B | 12.33B | 11.59B | 11.00B | 10.34B | 10.60B |
| Interest Income | 1.89M | 1.60M | 1.50M | 1.51M | 17.41M | 48.88M | 38.94M | 22.10M | 1.43M | 753.00K | 952.00K | 1.98M | 2.23M | 2.12M | 4.00M | 8.99M | 1.51M |
| Interest Expense | 213.38M | 179.89M | 172.32M | 169.25M | 161.62M | 148.08M | 116.93M | 106.72M | 111.69M | 119.27M | 128.04M | 97.67M | 89.96M | 124.75M | 127.64M | 104.98M | 20.20M |
| Depreciation & Amortization | 2.83B | 2.70B | 2.83B | 2.84B | 2.77B | 2.43B | 2.15B | 1.94B | 1.78B | 1.56B | 1.54B | 1.20B | 917.81M | 953.38M | 1.08B | 989.67M | 429.40M |
| EBITDA | 5.12B | 2.83B | 4.45B | 4.55B | 3.42B | 4.13B | 4.12B | 3.34B | 2.70B | 2.16B | 2.72B | 2.49B | 1.54B | 1.21B | 1.26B | -453.00M | -2.12B |
| EBITDA Ratio | 15.82% | 11.24% | 14.32% | 14.73% | 14.31% | 14.97% | 15.89% | 13.93% | 12.51% | 11.35% | 14.30% | 16.77% | 10.30% | 10.52% | 11.48% | 5.85% | 2.47% |
| Operating Income | 2.05B | 629.92M | 1.18B | 1.20B | 1.73B | 1.87B | 2.11B | 1.52B | 895.29M | 541.15M | 1.16B | 848.21M | 339.29M | 218.62M | 132.41M | -477.98M | -216.72M |
| Operating Income Ratio | 6.33% | 2.06% | 4.08% | 4.18% | 5.45% | 6.36% | 7.57% | 6.21% | 4.10% | 2.89% | 6.04% | 5.64% | 2.68% | 1.85% | 1.19% | -4.85% | -2.09% |
| Total Other Income/Expenses | 31.01M | -687.89M | 270.47M | 343.40M | -1.24B | -323.43M | -251.62M | -222.25M | -93.95M | -61.79M | -108.38M | 347.20M | 188.11M | -82.20M | -79.22M | -1.07B | -2.36B |
| Income Before Tax | 2.08B | -57.97M | 1.45B | 1.54B | 490.78M | 1.55B | 1.85B | 1.30B | 801.34M | 479.36M | 1.05B | 1.20B | 527.40M | 136.42M | 53.19M | -1.55B | -2.57B |
| Income Before Tax Ratio | 6.42% | -0.19% | 5.02% | 5.38% | 1.54% | 5.26% | 6.67% | 5.30% | 3.67% | 2.56% | 5.48% | 7.95% | 4.16% | 1.16% | 0.48% | -15.68% | -24.77% |
| Income Tax Expense | 117.66M | 294.95M | 255.11M | 372.87M | 293.57M | 587.17M | 656.45M | 419.94M | 308.67M | 262.90M | 594.61M | 226.31M | 340.06M | 21.44M | -68.49M | 110.16M | -937.60M |
| Net Income | 1.96B | -316.09M | 1.15B | 1.13B | 252.95M | 963.89M | 1.20B | 876.45M | 492.67M | 216.45M | 455.90M | 969.10M | 187.34M | 114.98M | 121.69M | -1.66B | -1.63B |
| Net Income Ratio | 6.06% | -1.03% | 4.00% | 3.95% | 0.80% | 3.27% | 4.31% | 3.58% | 2.26% | 1.16% | 2.38% | 6.44% | 1.48% | 0.97% | 1.09% | -16.80% | -15.74% |
| EPS | 77.40 | -12.63 | 46.09 | 45.13 | 10.10 | 38.50 | 47.87 | 35.01 | 19.24 | 8.43 | 19.61 | 41.94 | 8.11 | 4.98 | 5.27 | -67.90 | -66.07 |
| EPS Diluted | 77.40 | -12.63 | 46.09 | 45.13 | 10.10 | 38.50 | 47.87 | 35.01 | 19.24 | 8.43 | 19.61 | 41.94 | 8.11 | 4.98 | 5.27 | -67.90 | -66.07 |
| Weighted Avg Shares Out | 25.38M | 25.03M | 25.03M | 25.03M | 25.03M | 25.03M | 25.03M | 25.03M | 25.60M | 25.66M | 23.24M | 23.11M | 23.11M | 23.11M | 23.11M | 24.40M | 24.73M |
| Weighted Avg Shares Out (Dil) | 25.38M | 25.03M | 25.03M | 25.03M | 25.03M | 25.03M | 25.03M | 25.03M | 25.60M | 25.66M | 23.24M | 23.11M | 23.11M | 23.11M | 23.11M | 24.40M | 24.73M |
Source: https://incomestatements.info
Category: Stock Reports